41 results on '"Van Der Weyden, Carrie"'
Search Results
2. International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies
3. Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides
4. T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma
5. Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome
6. 288: Mycosis Fungoides with Large Cell Transformation: Radiotherapy Dose Response and Patient Outcomes
7. International Study of SS Shows Superiority of Combination Therapy & Heterogeneity of Treatment Strategies
8. CD30 ‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre
9. Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder
10. Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary Era
11. VEXAS syndrome: A dermatological perspective
12. Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma
13. Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome
14. Epigenetic Modifications in Lymphoma and Their Role in the Classification of Lymphomas
15. The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma
16. Advances in Frontline Management of Peripheral T-cell Lymphoma
17. Impact of Therapy Sequence on Survival Outcomes Among Patients with Relapsed or Refractory Mature T and NK Cell Neoplasms: A Global Retrospective Cohort Study
18. Novel Causal Inference Method Estimates Treatment Effects of Contemporary Drugs in a Global Cohort of Patients with Relapsed and Refractory Mature T-Cell and NK-Cell Neoplasms
19. Targeted Approaches to T-Cell Lymphoma
20. The gamma delta lymphomas: an Australian multi-centre case series
21. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement
22. Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
23. Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study
24. Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?
25. Primary cutaneous anaplastic large cell lymphoma and evolving clinical practice: 26 years of skin lesions with locoregional progression to systemic disease
26. Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis Fungoides
27. Brentuximab vedotin in T-cell lymphoma
28. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
29. Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.
30. IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma
31. Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome
32. Brentuximab vedotin in T-cell lymphoma.
33. Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium
34. Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement
35. Use of romidepsin for the treatment of mycosis fungoides and Sezary syndrome – role of romidepsin in the current therapeutic landscape and implications for future practice
36. High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from “orphan drug” to a standard-of-care?
37. The Mortality of Vancomycin-Resistant Enterococci Bloodstream Infections (VRE BSI)
38. Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.
39. High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from "orphan drug" to a standard-of-care?
40. 3377: Low-dose radiotherapy in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
41. Improving disease-specific survival for patients with Sezary syndrome in the modern era of systemic therapies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.